The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASE
Abstract
Neurological dysfunction, seizures and brain atrophy occur in a broad spectrum of acute and chronic neurological diseases. In certain instances, over-stimulation of N-methyl-D-aspartate receptors has been implicated. Quinolinic acid (QUIN) is an endogenous N-methyl-D-aspartate receptor agonist synthesized from L-tryptophan via the kynurenine pathway and thereby has the potential of mediating N-methyl-D-aspartate neuronal damage and dysfunction. Conversely, the related metabolite, kynurenic acid, is an antagonist of N-methyl-D-aspartate receptors and could modulate the neurotoxic effects of QUIN as well as disrupt excitatory amino acid neurotransmission. In the present study, markedly increased concentrations of QUIN were found in both lumbar cerebrospinal fluid (CSF) and post-mortem brain tissue of patients with inflammatory diseases (bacterial, viral, fungal and parasitic infections, meningitis, autoimmune diseases and septicaemia) independent of breakdown of the blood-brain barrier. The concentrations of kynurenic acid were also increased, but generally to a lesser degree than the increases in QUIN. In contrast, no increases in CSF QUIN were found in chronic neurodegenerative disorders, depression or myoclonic seizure disorders, while CSF kynurenic acid concentrations were significantly lower in Huntington's disease and Alzheimer's disease. In inflammatory disease patients, proportional increases in CSF L-kynurenine and reduced L-tryptophan accompanied the increases in CSF QUIN and kynurenic acid. These responses are consistent with induction of indoleamine-2,3-dioxygenase, the first enzyme of the kynurenine pathway which converts L-tryptophan to kynurenic acid and QUIN. Indeed, increases in both indoleamine-2,3-dioxygenase activity and QUIN concentrations were observed in the cerebral cortex of macaques infected with retrovirus, particularly those with local inflammatory lesions. Correlations between CSF QUIN, kynurenic acid and L-kynurenine with markers of immune stimulation (neopterin, white blood cell counts and IgG levels) indicate a relationship between accelerated kynurenine pathway metabolism and the degree of intracerebral immune stimulation. We conclude that inflammatory diseases are associated with accumulation of QUIN, kynurenic acid and L-kynurenine within the central nervous system, but that the available data do not support a role for QUIN in the aetiology of Huntington's disease or Alzheimer's disease. In conjunction with our previous reports that CSF QUIN concentrations are correlated to objective measures of neuropsychological deficits in HIV-1-infected patients, we hypothesize that QUIN and kynurenic acid are mediators of neuronal dysfunction and nerve cell death in inflammatory diseases. Therefore, strategies to attenuate the neurological effects of kynurenine pathway metabolites or attenuate the rate of their synthesis offer new approaches to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
Excitatory amino acid neurotoxicity and neurodegenerative disease
Meldrum, B., & Garthwaite, J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90184-a · Cited by 1,771
Chronic Fatigue Syndrome: A Working Case Definition
HOLMES, G. P., KAPLAN, J. E., GANTZ, N. M., KOMAROFF, A. L., SCHONBERGER, L. B., STRAUS, S. E., JONES, J. F., DUBOIS, R. E., CUNNINGHAM-RUNDLES, C., PAHWA, S., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-387 · Cited by 1,718
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Tibbling, G., Link, H., & Ohman, S. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091496 · Cited by 966
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Secretion of Neurotoxins by Mononuclear Phagocytes Infected with HIV-1
Giulian, D., Vaca, K., & Noonan, C. A. (1990) · Science · doi:10.1126/science.2148832 · Cited by 620
Heyes, M. P., Brew, B. J., Martin, A., Price, R. W., Salazar, A. M., Sidtis, J. J., Yergey, J. A., Mouradian, M. M., Sadler, A. E., Keilp, J., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410290215 · Cited by 571
Self-citationExcitatory Amino Acid Neurotransmission: NMDA Receptors and Hebb-Type Synaptic Plasticity
Cotman, C. W., & Monaghan, D. T. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000425 · Cited by 488
II. Excitotoxic models for neurodegenerative disorders
Schwarcz, R., Foster, A. C., French, E. D., Whetsell, W. O., & Köhler, C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90148-6 · Cited by 466
Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Self-citationFoster, A. C., Vezzani, A., French, E. D., & Schwarcz, R. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90050-8 · Cited by 434
NMDA Receptor Losses in Putamen from Patients with Huntington's Disease
Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D'Amato, C., Shoulson, I., & Penney, J. B. (1988) · Science · doi:10.1126/science.2841762 · Cited by 395
Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.
Takikawa, O., Yoshida, R., Kido, R., & Hayaishi, O. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35696-x · Cited by 377
Biological differences between ischemia, hypoglycemia, and epilepsy
Auer, R. N., & Siesjo, B. K. (1988) · Annals of Neurology · doi:10.1002/ana.410240602 · Cited by 331
l-Kynurenine Its synthesis and possible regulatory function in brain
G�l, E. M., & Sherman, A. D. (1980) · Neurochemical Research · doi:10.1007/bf00964611 · Cited by 318
Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.
Yoshida, R., Imanishi, J., Oku, T., Kishida, T., & Hayaishi, O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.129 · Cited by 292
Perkins, M. N., & Stone, T. W. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21648-2 · Cited by 215
3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims.
Schwarcz, R., Okuno, E., White, R. J., Bird, E. D., & Whetsell, W. O. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4079 · Cited by 184
Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys.
Lackner, A. A., Smith, M. O., Munn, R. J., Martfeld, D. J., Gardner, M. B., Marx, P. A., & Dandekar, S. (1991) · PubMed · Cited by 182
Self-citationWhetsell, W. O., & Schwarcz, R. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90609-5 · Cited by 175
Zinc alters excitatory amino acid neurotoxicity on cortical neurons
Koh, J., & Choi, D. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-06-02164.1988 · Cited by 136
Neuroactive kynurenines in Lyme borreliasis
Halperin, J., & Heyes, M. (1992) · Neurology · doi:10.1212/wnl.42.1.43 · Cited by 126
Self-citationA Comprehensive Immunological Analysis in Chronic Fatigue Syndrome
Gupta, S., & Vayuvegula, B. (1991) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1991.tb01777.x · Cited by 120
Brain Quinolinic Acid in Huntington's Disease
Reynolds, G. P., Pearson, S. J., Halket, J. M., & Sandier, M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02503.x · Cited by 109
Traumatic brain injuries: structural changes
Cervós‐Navarro, J., & Lafuente, J. V. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90002-o · Cited by 105
Immune Activation and Decreased Tryptophan in Patients with HIV-1 Infection
Fuchs, D., FORSMAN, A., Hagberg, L., LARSSON, M., Norkrans, G., Reibnegger, G. J., Werner, E. R., & WACHTER, H. (1990) · Journal of Interferon Research · doi:10.1089/jir.1990.10.599 · Cited by 102
Heyes, M. P., Jordan, E. K., Lee, K., Saito, K., Frank, J. A., Snoy, P. J., Markey, S. P., & Gravell, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)90587-y · Cited by 92
Self-citationMoroni, F., Lombardi, G., Carla�, V., Lal, S., Etienne, P. E., & Nair, N. P. V. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13071.x · Cited by 90
Foster, A. C., Whetsell, W. O., Bird, E. D., & Schwarcz, R. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90647-x · Cited by 83
Okuno, E., Köhler, C., & Schwarcz, R. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb00960.x · Cited by 80
Increased Cerebrospinal Fluid Quinolinic Acid, Kynurenic Acid, and L‐Kynurenine in Acute Septicemia
Heyes, M. P., & Lackner, A. A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08857.x · Cited by 80
Self-citationHeyes, M. P., & Quearry, B. J. (1988) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)83925-0 · Cited by 77
Self-citationHeyes, M. P., Quearry, B. J., & Markey, S. P. (1989) · Brain Research · doi:10.1016/0006-8993(89)90101-7 · Cited by 75
Self-citationVaresio, L., Clayton, M., Blasi, E., Ruffmann, R., & Radzioch, D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4265 · Cited by 72
Increase in Kynurenic Acid in Huntington's Disease Motor Cortex
Connick, J. H., Carla�, V., Moroni, F., & Stone, T. W. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb02552.x · Cited by 58
Larsson, M., Hagberg, L., Norkrans, G., & Forsman, A. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490230410 · Cited by 55
Heyes, M., & Quearry, B. (1990) · Journal of Chromatography A · doi:10.1016/s0378-4347(00)82308-7 · Cited by 52
Self-citationSaito, K., Lackner, A. A., Markey, S. P., & Heyes, M. P. (1991) · Brain Research · doi:10.1016/0006-8993(91)90536-5 · Cited by 49
Self-citationIncreased quinolinic acid metabolism following neuronal degeneration in the rat hippocampus
Speciale, C., Okuno, E., & Schwarcz, R. M. (1987) · Brain Research · doi:10.1016/0006-8993(87)91551-4 · Cited by 33
No changes in central quinolinic acid levels in Alzheimer's disease
Mourdian, M. M., Heyes, M. P., Pan, J.-B., Heuser, I. J. E., Markey, S. P., & Chase, T. N. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90043-8 · Cited by 31
Self-citationEffects of MK-801, ketamine and alaptide on quinolinate models in the maturing hippocampus
Keilhoff, G., Wolf, G. L., & Sˇtˇastný, F. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90382-x · Cited by 13
Quinolinic acid promotes the biochemical differentiation of cerebellar granule neurons
Hunt, A., & Patel, A. J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90475-o · Cited by 2
Cited by
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Tryptophan metabolism in health and disease
Xue, C., Li, G., Zheng, Q., Gu, X., Shi, Q., Su, Y., Chu, Q., Yuan, X., Bao, Z., Lu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.004 · Cited by 961
Metadata
- Authors
- HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., LARSEN, S. A., LEE, K., LEONARD, H. L., MARKEY, S. P., MARTIN, A., MILSTEIN, S., MOURADIAN, M. M., PRANZATELLI, M. R., QUEARRY, B. J., SALAZAR, A., SMITH, M., STRAUSS, S. E., SUNDERLAND, T., SWEDO, S. W., & TOURTELLOTTE, W. W.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1992
- Volume
- 115
- Issue
- 5
- Pages
- 1249-1273
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2010145371
- Cited by
- 680
- References
- 46
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.